NCT04305145 2026-01-29Infliximab for Treatment of Immune Checkpoint Inhibitor ColitisMassachusetts General HospitalPhase 2 Active not recruiting42 enrolled
NCT00676832 2010-09-29Study of COLAL-PRED to Treat Moderate to Severe Ulcerative ColitisPrometheus LaboratoriesPhase 2 Completed190 enrolled